Primary cardiac lymphoma

Adam Petrich, Soung Ick Cho, Henny H. Billett

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Background: Primary cardiac lymphoma (PCL) represents a rare subset of non-Hodgkin lymphoma, characterized by poor outcomes. The authors aimed to construct a framework of known clinical presentations, diagnostic features, disease complications, treatment, and outcomes to improve prognostication. Methods: Individual patient data were obtained from defined cases of PCL (1949-2009) and systematically analyzed. Results: The authors report results of a review of 197 cases of PCL, with half of all cases reported since 1995. Survival was affected by 4 factors: immune status, left ventricular involvement, presence of extra-cardiac disease, and arrhythmia. Median overall survival (OS) for immunocompromised and immunocompetent was 3.5 months (m) and not reached, respectively (HR 0.29, 95% CI, 0.13-0.68; P =.004). LV involvement was uncommon (26%) and associated with an OS of only 1m, whereas patients free of LV involvement had a median OS of 22m (HR 0.28, 95% CI, 0.12-0.64; P =.002). Patients with extracardiac disease had shorter median OS compared with those without (6m vs 22m, HR 0.49, 95% CI, 0.26-0.91; P =.02). Those patients with an arrhythmia of any type had a median OS that was not reached (n = 55), whereas those without rhythm disturbances (n = 41) had median OS of 6m (HR 0.51, 95% CI, 0.29-0.91; P =.024). Overall response rate to therapy was 84%, with long-term OS over 40%. Conclusions: The current study presents the largest analysis of PCL to date. The data demonstrate that PCL is now more frequently diagnosed premortem and appears to have reasonable response rates. Lack of LV involvement and the presence of arrhythmias are associated with improved survival.

Original languageEnglish (US)
Pages (from-to)581-589
Number of pages9
JournalCancer
Volume117
Issue number3
DOIs
StatePublished - Feb 1 2011

Fingerprint

Lymphoma
Survival
Cardiac Arrhythmias
Immunologic Factors
Non-Hodgkin's Lymphoma
Heart Diseases

Keywords

  • extra nodal lymphoma
  • immunocompromise
  • non-Hodgkin lymphoma
  • primary cardiac lymphoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Primary cardiac lymphoma. / Petrich, Adam; Cho, Soung Ick; Billett, Henny H.

In: Cancer, Vol. 117, No. 3, 01.02.2011, p. 581-589.

Research output: Contribution to journalArticle

Petrich, A, Cho, SI & Billett, HH 2011, 'Primary cardiac lymphoma', Cancer, vol. 117, no. 3, pp. 581-589. https://doi.org/10.1002/cncr.25444
Petrich, Adam ; Cho, Soung Ick ; Billett, Henny H. / Primary cardiac lymphoma. In: Cancer. 2011 ; Vol. 117, No. 3. pp. 581-589.
@article{0c2e852b0d2644b3bd7c5cc79f7aac23,
title = "Primary cardiac lymphoma",
abstract = "Background: Primary cardiac lymphoma (PCL) represents a rare subset of non-Hodgkin lymphoma, characterized by poor outcomes. The authors aimed to construct a framework of known clinical presentations, diagnostic features, disease complications, treatment, and outcomes to improve prognostication. Methods: Individual patient data were obtained from defined cases of PCL (1949-2009) and systematically analyzed. Results: The authors report results of a review of 197 cases of PCL, with half of all cases reported since 1995. Survival was affected by 4 factors: immune status, left ventricular involvement, presence of extra-cardiac disease, and arrhythmia. Median overall survival (OS) for immunocompromised and immunocompetent was 3.5 months (m) and not reached, respectively (HR 0.29, 95{\%} CI, 0.13-0.68; P =.004). LV involvement was uncommon (26{\%}) and associated with an OS of only 1m, whereas patients free of LV involvement had a median OS of 22m (HR 0.28, 95{\%} CI, 0.12-0.64; P =.002). Patients with extracardiac disease had shorter median OS compared with those without (6m vs 22m, HR 0.49, 95{\%} CI, 0.26-0.91; P =.02). Those patients with an arrhythmia of any type had a median OS that was not reached (n = 55), whereas those without rhythm disturbances (n = 41) had median OS of 6m (HR 0.51, 95{\%} CI, 0.29-0.91; P =.024). Overall response rate to therapy was 84{\%}, with long-term OS over 40{\%}. Conclusions: The current study presents the largest analysis of PCL to date. The data demonstrate that PCL is now more frequently diagnosed premortem and appears to have reasonable response rates. Lack of LV involvement and the presence of arrhythmias are associated with improved survival.",
keywords = "extra nodal lymphoma, immunocompromise, non-Hodgkin lymphoma, primary cardiac lymphoma",
author = "Adam Petrich and Cho, {Soung Ick} and Billett, {Henny H.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1002/cncr.25444",
language = "English (US)",
volume = "117",
pages = "581--589",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Primary cardiac lymphoma

AU - Petrich, Adam

AU - Cho, Soung Ick

AU - Billett, Henny H.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Background: Primary cardiac lymphoma (PCL) represents a rare subset of non-Hodgkin lymphoma, characterized by poor outcomes. The authors aimed to construct a framework of known clinical presentations, diagnostic features, disease complications, treatment, and outcomes to improve prognostication. Methods: Individual patient data were obtained from defined cases of PCL (1949-2009) and systematically analyzed. Results: The authors report results of a review of 197 cases of PCL, with half of all cases reported since 1995. Survival was affected by 4 factors: immune status, left ventricular involvement, presence of extra-cardiac disease, and arrhythmia. Median overall survival (OS) for immunocompromised and immunocompetent was 3.5 months (m) and not reached, respectively (HR 0.29, 95% CI, 0.13-0.68; P =.004). LV involvement was uncommon (26%) and associated with an OS of only 1m, whereas patients free of LV involvement had a median OS of 22m (HR 0.28, 95% CI, 0.12-0.64; P =.002). Patients with extracardiac disease had shorter median OS compared with those without (6m vs 22m, HR 0.49, 95% CI, 0.26-0.91; P =.02). Those patients with an arrhythmia of any type had a median OS that was not reached (n = 55), whereas those without rhythm disturbances (n = 41) had median OS of 6m (HR 0.51, 95% CI, 0.29-0.91; P =.024). Overall response rate to therapy was 84%, with long-term OS over 40%. Conclusions: The current study presents the largest analysis of PCL to date. The data demonstrate that PCL is now more frequently diagnosed premortem and appears to have reasonable response rates. Lack of LV involvement and the presence of arrhythmias are associated with improved survival.

AB - Background: Primary cardiac lymphoma (PCL) represents a rare subset of non-Hodgkin lymphoma, characterized by poor outcomes. The authors aimed to construct a framework of known clinical presentations, diagnostic features, disease complications, treatment, and outcomes to improve prognostication. Methods: Individual patient data were obtained from defined cases of PCL (1949-2009) and systematically analyzed. Results: The authors report results of a review of 197 cases of PCL, with half of all cases reported since 1995. Survival was affected by 4 factors: immune status, left ventricular involvement, presence of extra-cardiac disease, and arrhythmia. Median overall survival (OS) for immunocompromised and immunocompetent was 3.5 months (m) and not reached, respectively (HR 0.29, 95% CI, 0.13-0.68; P =.004). LV involvement was uncommon (26%) and associated with an OS of only 1m, whereas patients free of LV involvement had a median OS of 22m (HR 0.28, 95% CI, 0.12-0.64; P =.002). Patients with extracardiac disease had shorter median OS compared with those without (6m vs 22m, HR 0.49, 95% CI, 0.26-0.91; P =.02). Those patients with an arrhythmia of any type had a median OS that was not reached (n = 55), whereas those without rhythm disturbances (n = 41) had median OS of 6m (HR 0.51, 95% CI, 0.29-0.91; P =.024). Overall response rate to therapy was 84%, with long-term OS over 40%. Conclusions: The current study presents the largest analysis of PCL to date. The data demonstrate that PCL is now more frequently diagnosed premortem and appears to have reasonable response rates. Lack of LV involvement and the presence of arrhythmias are associated with improved survival.

KW - extra nodal lymphoma

KW - immunocompromise

KW - non-Hodgkin lymphoma

KW - primary cardiac lymphoma

UR - http://www.scopus.com/inward/record.url?scp=79251508665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251508665&partnerID=8YFLogxK

U2 - 10.1002/cncr.25444

DO - 10.1002/cncr.25444

M3 - Article

VL - 117

SP - 581

EP - 589

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3

ER -